FDA Approved: PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND) — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved the original application for paclitaxel protein-bound particles for injectable suspension (albumin-bound) from BluePoint Laboratories. This represe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• Paclitaxel protein-bound particles for injectable suspension (albumin-bound) (paclitaxel)

Snippet

ORIG AP for PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND) (PACLITAXEL)